Clinical Applications: Chronic viral infections (hepatitis B/C, Lyme disease) Immune deficiency states Cancer immunotherapy support Autoimmune condition modulation Recovery from severe illness or surgery Dosing: Typically 1.6-3.2 mg subcutaneously, 2-3 times per week for immune support, or daily for acute conditions
In this type of scenario, where few things can bring a sense of control, a leader's biology is one of the few domains where they can still exert direct control
Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells
Tesamorelin adds visceral fat reduction (directly addressing the obesity component), improved body composition (supporting metabolic rate), and potential cardiovascular benefits through reduction of the inflammatory visceral fat depot
How Long Until I See Visible Results